FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS

被引：0

作者：

Gugliotta, G. ^{[1
]}

Castagnetti, F. ^{[1
]}

Breccia, M. ^{[2
]}

Levato, L. ^{[3
]}

Fava, C. ^{[4
]}

Luciano, L. ^{[5
]}

Zaccaria, A. ^{[6
]}

Rossi, A. Russo ^{[7
]}

Usala, E. ^{[8
,9
]}

Gozzini, A. ^{[10
]}

Vigneri, P. ^{[11
]}

Cedrone, M. ^{[12
]}

Tiribelli, M. ^{[13
,14
]}

Abruzzese, E. ^{[15
]}

Avanzini, P. ^{[16
]}

Palandri, F. ^{[1
]}

Soverini, S. ^{[1
]}

Alimena, G. ^{[2
]}

Pane, F. ^{[5
]}

Martinelli, G. ^{[1
]}

Cavo, M. ^{[1
]}

Saglio, G. ^{[4
]}

Baccarani, M. ^{[17
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Dept Hematol, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Div Internal Med Hematol, Turin, Italy

[5] Univ Naples Federico II, Dept Hematol CEINGE & Adv Biotechonolgies, Naples, Italy

[6] IRST IRCCS, Hematol Unit, Meldola, Forli Cesena, Italy

[7] Univ Bari, Dept Emergency & Organ Transplantat, Hematol Unit, Bari, Italy

[8] Armando Businco Hosp, Cagliari, Italy

[9] Armando Businco Hosp, Bone Marrow Transplantat Unit, Cagliari, Italy

[10] Univ Florence, Careggi Hosp, Dept Hematol, Florence, Italy

[11] Univ Catania, Ferrarotto Hosp, Div Hematol, Catania, Italy

[12] San Giovanni Hosp, Hematol Unit, Rome, Italy

[13] Univ Udine, Dept Expt & Clin Med Sci, Div Hematol, I-33100 Udine, Italy

[14] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy

[15] S Eugenio Hosp, Dept Hematol, Rome, Italy

[16] Santa Maria Nuova Hosp, Hematol Unit, Reggio Emilia, Italy

[17] Univ Bologna, Bologna, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P892

引用

页码：333 / 333

页数：1

共 50 条

[11] Impact of Arterial Thrombotic Events on the Outcome of Chronic Myeloid Leukemia Patients Treated with Nilotinib First-Line: A GIMEMA CML WP Analysis
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
D'Adda, Mariella
Stagno, Fabio
Levato, Luciano
Carella, Angelo Michele
Martino, Bruno
Tiribelli, Mario
Rege-Cambrin, Giovanna
Gozzini, Antonella
Salvucci, Marzia
Cedrone, Michele
Trabacchi, Elena
Usala, Emilio
Scortechini, Anna Rita
Luciano, Luigia
Soverini, Simona
Cavo, Michele
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S313 - S314
[12] Imatinib mesylate determines a high frequency of major molecular responses in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia (CML) on behalf of the GIMEMA working party on chronic myeloid leukemia (GIMEMA-CML).
Lacobucci, I
Testoni, N
Rosti, G
Amabile, M
Poerio, A
Soverini, S
Colarossi, S
Gnani, A
Ottaviani, E
Castagnetti, F
Terragna, C
Renzulli, M
Grafone, T
Cilloni, D
Pane, F
Saglio, G
Baccarani, M
BLOOD, 2005, 106 (11) : 320A - 320A
[13] Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party
Rosti, Gianantonio
Iacobucci, Ilaria
Bassi, Simona
Castagnetti, Fausto
Amabile, Marilina
Cilloni, Daniela
Poerio, Angela
Soverini, Simona
Palandri, Francesca
Cambrin, Giovanna Rege
Iuliano, Franco
Alimena, Giuliana
Latagliata, Roberto
Testoni, Nicoletta
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Martinelli, Giovanni
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 101 - 105
[14] PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP
Castagnetti, F.
Gugliotta, G.
Breccia, M.
Specchia, G.
Binotto, G.
Abruzzese, E.
Iurlo, A.
Vigneri, P.
Cavazzini, F.
Intermesoli, T.
Ferrero, D.
Martino, B.
Leoni, P.
Bocchia, M.
Rege-Cambrin, G.
Gherlinzoni, F.
Bochicchio, M. T.
Soverini, S.
Alimena, G.
Pane, F.
Saglio, G.
Cavo, M.
Martinelli, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2015, 100 : 324 - 324
[15] INCIDENCE OF ABL KINASE DOMAIN MUTATIONS IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH FAILURE OR SUBOPTIMAL RESPONSE TO FRONTLINE IMATINIB TREATMENT - AN ANALYSIS BY THE GIMEMA WORKING PARTY ON CML
Soverini, S.
Colarossi, S.
Gnani, A.
Castagnetti, F.
Abruzzese, E.
Orlandi, E.
Tiribelli, M.
Breccia, M.
Specchia, G.
Palandri, F.
Poerio, A.
Amabile, M.
Iacobucci, I.
Ciccarese, F.
Rosti, G.
Baccarani, M.
Martinelli, G.
HAEMATOLOGICA, 2008, 93 : S71 - S71
[16] CARDIOVASCULAR EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FIRST-LINE: AN ANALISYS OF THE GIMEMA CML WP
Gugliotta, G.
Castagnetti, F.
Breccia, M.
Stagno, F.
Martino, B.
Fava, C.
Luciano, L.
Gozzini, A.
Carella, A. M.
Abruzzese, E.
Levato, L.
Usala, E.
Rossi, G.
Bocchia, M.
Tiribelli, M.
Cavazzini, F.
Salvucci, M.
Cedrone, M.
Trabacchi, E.
Binotto, G.
Venturi, C.
Soverini, S.
Cavo, M.
Specchia, G.
Alimena, G.
Pane, F.
Martinelli, G.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2015, 100 : 56 - 56
[17] Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
Mauro, Michael J.
Dakhil, Shaker
Cortes, Jorge E.
Rizzieri, David A.
Keir, Christopher H.
Yi, Sandy
Heinrich, Michael C.
Goldberg, Stuart L.
Catchatourian, Rosalind
Kuriakose, Philip
Radich, Jerald P.
BLOOD, 2014, 124 (21)
[18] COST-UTILITY ANALYSIS OF NILOTINIB COMPARED TO IMATINIB FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE
Inocencio, T. J.
Seetasith, A.
Newland, A.
Bose, P.
Holdford, D.
VALUE IN HEALTH, 2012, 15 (04) : A223 - A223
[19] Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis
Castagnetti, Fausto
Testoni, Nicoletta
Luatti, Simona
Marzocchi, Giulia
Mancini, Marco
Kerim, Simonetta
Giugliano, Emilia
Albano, Francesco
Cuneo, Antonio
Abruzzese, Elisabetta
Martino, Bruno
Palandri, Francesca
Amabile, Marilina
Iacobucci, Ilaria
Alimena, Giuliana
Pane, Fabrizio
Martinelli, Giovanni
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2748 - 2754
[20] Comparison of cytogenetics and interphase fluorescence in situ hybridization in newly diagnosed Ph plus chronic myeloid leukemia patients treated with imatinib mesylate. A study by the GIMEMA working party on CML. On behalf of GWP on CML.
Testoni, N
Luatti, S
Nicci, C
Montanari, E
Marzocchi, G
Specchia, G
Mancini, M
Abruzzese, E
Rege-Cambrin, G
Cuneo, A
Kerim, S
Giussani, U
Bernasconi, P
Mecucci, C
Zaccaria, A
Discepoli, G
Martinelli, G
Rosti, G
Baccarani, M
BLOOD, 2005, 106 (11) : 294B - 294B

← 1 2 3 4 5 →